Literature DB >> 10477138

Ser-322 is a critical site for PKC regulation of the MDCK cell taurine transporter (pNCT).

X Han1, A M Budreau, R W Chesney.   

Abstract

Previous studies have shown that the Madin-Darby canine kidney cell taurine transporter (pNCT) is downregulated by protein kinase C (PKC) activation. In this study, it is hypothesized that the highly conserved serine-322 (Ser-322) located in the fourth intracellular segment (S4) may play an important role in the function of taurine transporter, which is modulated by PKC phosphorylation. It is demonstrated that Ser-322 is the critical site of PKC phosphorylation, as determined by site-directed mutagenesis. When Ser-322 of pNCT was changed to alanine (S322A) and this mutant was evaluated in an oocyte expression system, taurine transport activity increased threefold compared with control (wild-type pNCT). Activation of PKC by the active phorbol ester 12-myristate 13-acetate did not influence taurine transport by mutant S322A. Kinetic analysis showed that the mutation of Ser-322 essentially changed the Vmax, rather than the Km, of the transporter. Mutation of all other PKC consensus sites did not affect transporter activity when expressed in the oocyte system. Western blot analysis showed that expression of taurine transporter protein was similar in oocytes injected with either wild-type or mutant pNCT cRNA, indicating that the enhanced taurine transport activity by mutant S322A was not caused by a greater amount of transporter expressed in the oocyte. Furthermore, this study demonstrated that the taurine transporter was phosphorylated after PKC activation, and this effect was not observed in mutant S322A. In conclusion, Ser-322 is critical in PKC regulation of taurine transporter activity. The steady-state taurine transporter activity is tightly controlled by endogenous PKC phosphorylation of Ser-322, which is located in the fourth intracellular segment of the taurine transporter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477138     DOI: 10.1681/ASN.V1091874

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Taurine and proliferation of lymphocytes in physically restrained rats.

Authors:  Fili Fazzino; Francisco Obregón; Lucimey Lima
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 2.  Regulation of the cellular content of the organic osmolyte taurine in mammalian cells.

Authors:  Ian Henry Lambert
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 3.  Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations.

Authors:  M L Tappaz
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 4.  SLC6 transporters: structure, function, regulation, disease association and therapeutics.

Authors:  Akula Bala Pramod; James Foster; Lucia Carvelli; L Keith Henry
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

5.  Regulation of taurine transport in rat hippocampal neurons by hypo-osmotic swelling.

Authors:  James E Olson; Eduardo Martinho
Journal:  J Neurochem       Date:  2006-03       Impact factor: 5.372

6.  Cloning, tissue and ontogenetic expression of the taurine transporter in the flatfish Senegalese sole (Solea senegalensis).

Authors:  Wilson Pinto; Ivar Rønnestad; Ann-Elise Olderbakk Jordal; Ana S Gomes; Maria Teresa Dinis; Cláudia Aragão
Journal:  Amino Acids       Date:  2011-01-06       Impact factor: 3.520

7.  Maternal obesity is associated with a reduction in placental taurine transporter activity.

Authors:  A M Ditchfield; M Desforges; T A Mills; J D Glazier; M Wareing; K Mynett; C P Sibley; S L Greenwood
Journal:  Int J Obes (Lond)       Date:  2014-12-30       Impact factor: 5.095

8.  Taurine transport in human placental trophoblast is important for regulation of cell differentiation and survival.

Authors:  M Desforges; L Parsons; M Westwood; C P Sibley; S L Greenwood
Journal:  Cell Death Dis       Date:  2013-03-21       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.